Compounds for treatment of cancer
US11084811B2 · kind B2 · utility
2Cited by
13References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 21, 2019 |
| Grant date | Aug 10, 2021 |
| Priority date | — |
| Expiry date | Feb 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.